Skip to content

Cellaïon

In liquidation since 03-06-2024 Public limited companyfounded 2021Rue Granbonpré 11, 1435 Mont-Saint-GuibertKBO/BCE: BE 0764.522.425

No group

Cellaïon has no parent and no holdings in its annual accounts.

At the same address

Rue Granbonpré 11, 1435 Mont-Saint-Guibert · 35 other companies
LHOIST
establishment since 21-12-2015 · founded in 1996 · group Financière de Gestions Internationales
turnover €674.6m (2025)
0459.399.522
CARRIERES ET FOURS A CHAUX DUMONT-WAUTIER
establishment since 21-12-2015 · founded in 1924 · group Financière de Gestions Internationales
219 FTE (2025)
0403.948.679
FIRMENICH BELGIUM
establishment since 01-12-2013 · founded in 1973 · group DSM-Firmenich AG
275 FTE (2025)
0413.672.534
NOVADIP BIOSCIENCES
registered office since 14-06-2013 · founded in 2013
39 FTE (2025)
0535.575.602
HAYS SERVICES
establishment since 01-10-2011 · founded in 2009
51 FTE (2025)
0810.328.694
Clinigen Clinical Supplies Management
registered office since 01-08-2003 · founded in 2003
119 FTE (2025)
0859.906.087
LHOIST RECHERCHE ET DEVELOPPEMENT
establishment since 21-12-2015 · founded in 1988 · group Financière de Gestions Internationales
95 FTE (2025)
0434.971.655
HAYS
establishment since 11-05-2006 · founded in 1991
388 FTE (2025)
0443.465.291
DE SMET S.A. - ENGINEERS & CONTRACTORS
registered office since 11-12-1989 · founded in 1989
88 FTE (2025)
0438.987.752
Forvis Mazars Bedrijfsrevisoren
establishment since 30-12-2020 · founded in 1986
150 FTE (2025)
0428.837.889
and 25 more

Earlier ties

Ncardia Holding
via A Q INVEST, no longer at Ncardia Holding · Director · deed of 02-12-2021
founded in 2014
total assets €108.4m (2025)
HEPATIC CELL THERAPY SUPPORT
via ABDA LILLY, at Cellaïon, last mentioned in 2021 · Director · deed of 20-10-2020
No longer active
total assets €13.6m (2021)

Acquisitions and mergers

1 transaction
Received a branch of activity from:PROMETHERA BIOSCIENCES
BE 0809.788.365Gazette deed of 09-02-2022 (2 deeds) · effective 17-01-2022

Connections & network

4 connected companies
Linked via shared directors
Newton Biocapital II Partners
via A Q INVEST · Director (not named in the articles) · deed of 06-05-2021
Founded in 2021 · total assets €49,225 (2025) · negative equity
→
EPICS THERAPEUTICS
via A Q INVEST · Director · deed of 04-03-2019
Founded in 2018 · 32 FTE (2025)
→
DEXOWL
via A Q INVEST · Director · deed of 24-03-2021
No longer active · founded in 2018 · total assets €13.4m (2024)
→
Dim3
via A Q INVEST · Director · deed of 11-08-2017
No longer active · founded in 2004 · total assets €33,530 (2025)
→